This study provides significant evidence that zinc supplementation in patients undergoing maintenance hemodialysis due to chronic kidney disease and end-stage renal disease leads to a notable reduction in key inflammatory biomarkers, specifically C-reactive protein and the neutrophil-to-lymphocyte ratio. This evidence concerns the gene CRP and chronic kidney disease.